- Home
- / IsoPlexis
IsoPlexis
Revenue
$16.8 M
FY, 2022
IsoPlexis Summary
Company Summary
- Overview
- IsoPlexis is a company that develops a diagnostic platform for immunology research and therapeutic development. It offers diagnosis kits, instrumentation, and software and focuses on cancer immunology, infectious disease, vaccines, cellular and regenerative medicine, inflammation, neurology, and oncology.
- Type
- Subsidiary
- Status
- Closed
- Founded
- 2013
- HQ
- Branford, CT, US | view all locations
- Website
- https://isoplexis.com/
- Cybersecurity rating
Table of Contents
LocationsView all
3 locations detected
Branford, CT HQ
United States
35 NE Industrial Rd
Shanghai, Shang Hai Shi
China
512 West Haiyang Road, Pudong District
Birmingham, England
United Kingdom
Front, Suite 1st Floor, charles house, 148-149 Great Charles Street Queensway
IsoPlexis Financials
Summary Financials
- Revenue (FY, 2022)
- $16.8M
- Gross profit (FY, 2022)
- ($925.0K)
- Net income (FY, 2022)
- ($106.0M)
- Cash (FY, 2022)
- $37.5M
- EBIT (FY, 2022)
- ($101.2M)